1. Identify when molecular testing should be considered in the evaluation of indeterminate thyroid nodules.
2. Discuss differences in test methodology and summarize performance characteristics.
3. Use genomic information in inform prognosis and management.
04/24/2023 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Sarah Mayson, M.D.